Day One Biopharmaceuticals, Inc. Common Stock (DAWN)
PHARMACEUTICAL PREPARATIONS
Day One Biopharmaceuticals, Inc. Common Stock (DAWN) was listed on Nasdaq from May 27, 2021 and stopped trading under the symbol DAWN on April 24, 2026.
- Listed On
- Nasdaq
- Listed Since
- May 27, 2021
- Stopped Trading
- April 24, 2026
- Employees
- 178
About Day One Biopharmaceuticals, Inc. Common Stock
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 2 institutions reported holding DAWN, with 165 shares worth $3,552 in aggregate. The largest reported holder was Ifp Advisors, with 165 shares worth $3,552. Of the 2 largest holders listed below, 1 reduced its position and 1 sold out during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Ifp Advisors | 165 | $4K | Reduced 74.22% |
| Janus Henderson (Jupiter Topco) | Sold out |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is DAWN?
Day One Biopharmaceuticals, Inc. Common Stock (DAWN) was listed on Nasdaq from May 27, 2021 and stopped trading under the symbol DAWN on April 24, 2026.
Who are the largest institutional holders of DAWN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of DAWN were Ifp Advisors and Janus Henderson (Jupiter Topco).
How many institutions own DAWN?
2 institutions reported a position in DAWN for the quarter ended June 30, 2026, worth $3,552 in total.
Did institutions buy or sell DAWN last quarter?
Of the 2 largest reported holders, 1 reduced its position and 1 sold out during the quarter. Every reported holder and its change is on the SentiSense ownership page for DAWN.
Every reported institutional holder, plus insider and congressional trades in DAWN, on SentiSense.